This month’s magazine includes the latest news, from Novo Nordisk’s Wegovy being made available in the UK (
page 4) and the Medicines and Healthcare products Regulatory Agency granting marketing authorisation to AbbVie’s Aquipta for migraine treatment (
page 8), to the National Institute for Health and Care Excellence publishing draft guidance for the use of AI in radiotherapy treatment planning (
page 11) and Abbott acquiring Bigfoot Biomedical (
page 12).